COPD Trial, Recruiting (NCT06802003)

COPD Trial, Recruiting NCT06802003 Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT06802003 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 40 or older who currently smoke or used to smoke, with a smoking history of at least 10 pack-years (roughly 10 years of smoking one pack per day, or an equivalent amount)
People who have been diagnosed with moderate, severe, or very severe COPD, based on specific breathing test results (confirm with trial site for exact measurements)
People who have had 2 or more COPD flare-ups in the past 12 months that needed treatment with steroids, antibiotics, or both
People who are able to give their informed consent to take part in the trial
People who are able to access the internet at least once every day

Who may not be able to join:

People who do not have an existing COPD diagnosis
People who have a medical, cognitive, or physical condition that would prevent them from using the research equipment or devices, or from completing daily symptom checks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (514) 843-1465

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06802003

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: (514) 843-1465

More information: https://clinicaltrials.gov/study/NCT06802003

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 40 or older who currently smoke or used to smoke, with a smoking history of at least 10 pack-years (roughly 10 years of smoking one pack per day, or an equivalent amount)
People who have been diagnosed with moderate, severe, or very severe COPD, based on specific breathing test results (confirm with trial site for exact measurements)
People who have had 2 or more COPD flare-ups in the past 12 months that needed treatment with steroids, antibiotics, or both
People who are able to give their informed consent to take part in the trial
People who are able to access the internet at least once every day

Who may not be able to join:

People who do not have an existing COPD diagnosis
People who have a medical, cognitive, or physical condition that would prevent them from using the research equipment or devices, or from completing daily symptom checks

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Registry

ClinicalTrials.gov

Start date

22 May 2025

Est. completion

31 May 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Respiration; Cardiovascular; Oxygen level; Step count; Sleep duration; Rapid eye movement (REM) sleep; Deep sleep; Body temperature; Resistance at 5 Hz (R5); Reactance at 5 Hz (X5); Intra-breath difference between expiratory and inspiratory reactance (ΔXrs); Tidal volume (Vt); Respiratory flows; Respiratory rate (RR); Minute ventilation (Ve); Heart rate (HR) prior oscillometry test; Blood oxygen saturation (SpO2) prior oscillometry test; Daily symptom questionnaire; Weekly exacerbation questionnaire; Calories; Metabolic equivalents; Movement intensity; Sleep efficiency; Sleep oncet; Sleep dist...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov